The PSA assay has little potential to detect PCa at an early stage, the biomarkers HSP27 and Menin have the potential not only to detect the disease at an early stage to reduce cancer mortality and increase patient survival but also to differentiate true and false positive PCa screens. The gene discussed is KLK3; the disease is posterior cortical atrophy.